Russia extends human cloning ban
By RIA Novosti,
RIA Novosti
| 10. 02. 2009
Russia has decided to extend a moratorium on human cloning that expired two years ago by five years, the health and social development minister said on Friday.
Tatyana Golikova said the moratorium, which ended on June 23, 2007, "only applies to human cloning."
It was not entirely clear why it was not prolonged at the time or whether any human cloning experiments had been carried out in Russia during the past two years.
She added that "the law does not extend to the cloning of any other species."
The minister said the moratorium, backed by the Russian Academy of Sciences and the Russian Academy of Medical Sciences, was in line with a UN cloning declaration.
In March 2005, the UN adopted a non-binding Declaration on Human Cloning, calling for the prohibition of all forms of human cloning contrary to human dignity.
Related Articles
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...
By Anna Collinson, Maryam Ahmed and Bella McShane, BBC | 03.12.2024
Women who freeze their eggs are being misled by some UK clinics about their chances of having a baby, a fertility charity says.
The Fertility Network was reacting to BBC analysis that found 41% of clinics offering the service privately...
By Isabelle Bartram, Guest Contributor
| 03.13.2024
Note: This article was originally published in February 2024 in issue 268 of the German-language journal Der Gen-ethische Informationsdienst (GID). It is also part of an English-language dossier on Heritable Human Genome Editing published at the same time. Minor edits have been made.
Calls for German embryo research
Pressure on the German Embryo Protection Act is growing. The scientific community is launching a renewed attack on the controversial law and demands access to embryos for so-called high-ranking research objectives. "Germline therapies" are...
By Andrew Joseph, STAT | 02.22.2024
In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies.
But as the country marks two years this...